You are viewing the site in preview mode

Skip to main content

Table 1 Demographics and surgery characteristics

From: Determination of the ED95 of intrathecal hyperbaric prilocaine with sufentanil for scheduled cesarean delivery: a dose-finding study based on the continual reassessment method

Dose 35 mg (n = 4) 40 mg (n = 12) 45 mg (n = 20) 50 mg (n = 4)
Age (y) 29 ± 8,76 35,08 ± 5,11 32,85 ± 4,93 29 ± 5,94
Length (cm) 159,5 ± 4,93 164,42 ± 4,45 162,8 ± 6,26 157 ± 6,16
Weight (kg) 73 ± 16,02 82,17 ± 11,93 79,78 ± 11,6 84,68 ± 2,88
Gravity 3 ± 1,41 2,17 ± 1,03 3,1 ± 2,31 2 ± 1,41
Parity 1,25 ± 0,5 0,67 ± 0,49 1,3 ± 1,98 0,75 ± 0,96
Had previous CS (n) 2 5 10 1
Term (w) 38,5 ± 0,58 38,42 ± 1,08 38,40 ± 0,94 38,75 ± 1,26
Time to baby extraction (min) 12,00 8,00 ± 3,49 8,05 ± 2,95 10,25 ± 6,95
Time of surgery (min) 53,00 50,09 ± 14,02 49,32 ± 9,90 56,00 ± 15,64
  1. Data for surgery characteristics (Time to baby extraction and time of surgery) was recorded only if success:
  2. 1 patient for the dose of 35 mg, 11 patients for 40 mg, 19 for 45 mg, 4 for 50 mg